About BISC Global
BISC Global is a company based in Ghent (Belgium) founded in 2017 was acquired by Excelra in April 2023. The company has 15 employees. BISC Global operates in a competitive market with competitors including Rejuvenate Bio, Novogene Corporation, Clinical Microbiomics, BGI and Genewiz, among others.
- Headquarter Ghent, Belgium
- Employees 15
- SectorsHealthcare
- Website biscglobal.com
- Acquired by Excelra (Apr 2023)
- Legal Name Bisc Global
Investors in BISC Global
BISC Global has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Excelra.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Bioinformatics platform developed for in silico analysis of drug candidates. | 2001 | excelra.com | Hyderabad, India |
Investor details for BISC Global
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of BISC Global
8 people are tracked at BISC Global (3 in leadership, 5 in team); the tracked headcount is 15.
| Name | Role | Group |
|---|---|---|
Anandbir Singh Brar | CEO | Leadership |
Maarten Braspenning | Founder & CEO | Leadership |
Stephani Lane | Senior US HR Business Partner | Leadership |
Ngoc Pham | Senior Consultant, Machine Learning, Bioinformatics | Team |
Candice Brown | Business Manager | Team |
Siebe Vandecasteele | Business Development Manager | Team |
Rich Johnson | Business Manager, US West | Team |
Lynn Verbeke | Senior Consultant & Team Leader, EU | Team |
Complete people profiles for BISC Global
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of BISC Global
2 dated milestones of BISC Global across 6 years, from founding to its latest funding, stage changes and deals.
- Founded BISC Global is founded.
- Exit Acquired by Excelra.
Competitors of BISC Global
BISC Global operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rejuvenate Bio, Novogene Corporation, Clinical Microbiomics, BGI and Genewiz, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| rejuvenatebio.com | 2017 | San Diego, United States | $14.58M | 39 | Gene-editing platform and anti-aging therapy for dogs are developed. | |
| novogene.com | 2011 | Beijing, China | $75M | 141 | Genomic services and solutions with NGS expertise are provided. | |
| clinical-microbiomics.com | 2016 | Horsholm, Denmark | $9.71M | 35 | Meta-genomics platforms and services for microbiome studies are provided. | |
| bgi.com | 1999 | Shenzhen, China | – | 25 | BGI is engaged in genomics and precision medicine solutions. | |
| genewiz.com | 1999 | South Plainfield, United States | – | 452 | Genomic services are provided for the life sciences industry. | |
| basecare.cn | 2010 | Suzhou, China | $36.52M | – | NGS-based diagnostic solutions for neonatal screening are developed. | |
| enarabio.com | 2016 | Oxford, United Kingdom | $84.05M | 38 | T-cell interfaces for cancer therapeutics are developed. | |
| 20n.com | 2013 | San Francisco, United States | $2.22M | – | Computational tools are developed to engineer microbes for synthetic biology. | |
| solexa.com | 1992 | Hayward, United States | $14.4M | – | Develops Genome sequencing technology | |
| sourcebioscience.com | 1903 | Nottingham, United Kingdom | – | 273 | Multiple genomic services are provided for analysis and diagnostics. |
Detailed competitors of BISC Global
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BISC Global
The website of BISC Global (biscglobal.com) receives about 2.2K visits a month.
- Monthly visits2.2K
▲ 81.9% vs previous month
Latest news on Bisc Global
Complete news archive for BISC Global
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to BISC Global
10 companies that operate in the same segment as BISC Global (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BISC Global
BISC Global was founded in 2017.
BISC Global is headquartered in Ghent, Belgium. It is registered at Ghent, East Flanders, Belgium.
Anandbir Singh Brar is the current CEO of BISC Global.
BISC Global has 15 employees.
BISC Global was established in 2017 in Ghent, Belgium, as a provider of bioinformatics and biostatistics services. Support is offered to life science companies through data analysis, statistical modeling, and computational tools for research applications. Operations are centered in the European life sciences sector, with services addressing needs in pharmaceuticals and biotechnology. Leadership is held by CEO Anandbir Singh Brar, overseeing delivery to clients in the region.
BISC Global's top competitors include Novogene Corporation, BGI and Source BioScience.
BISC Global has 1 investor. Key investors include Excelra.
BISC Global operates through Bisc Global.
Yes. BISC Global was acquired by Excelra in April 2023.